This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-106a-5p | AKT3 | -0.19 | 0.7766 | 0.2 | 0.64987 | miRNATAP | -0.12 | 0.02117 | NA | |
2 | hsa-miR-106b-5p | AKT3 | -0.11 | 0.91815 | 0.2 | 0.64987 | miRNATAP | -0.41 | 1.0E-5 | NA | |
3 | hsa-miR-142-3p | AKT3 | 0.04 | 0.97824 | 0.2 | 0.64987 | miRanda | -0.16 | 0.00934 | NA | |
4 | hsa-miR-15a-5p | AKT3 | -0.01 | 0.99353 | 0.2 | 0.64987 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.37 | 0.00021 | NA | |
5 | hsa-miR-15b-5p | AKT3 | 0.01 | 0.99351 | 0.2 | 0.64987 | miRNATAP | -0.25 | 0.00571 | NA | |
6 | hsa-miR-16-5p | AKT3 | 0.01 | 0.99567 | 0.2 | 0.64987 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 0.00086 | NA | |
7 | hsa-miR-17-5p | AKT3 | -0 | 0.99959 | 0.2 | 0.64987 | TargetScan; miRNATAP | -0.17 | 0.02914 | NA | |
8 | hsa-miR-29b-2-5p | AKT3 | 0.05 | 0.91445 | 0.2 | 0.64987 | mirMAP | -0.23 | 0.01747 | NA | |
9 | hsa-miR-29b-3p | AKT3 | 0.14 | 0.9001 | 0.2 | 0.64987 | miRNATAP | -0.28 | 0.00031 | 26512921 | MicroRNA 29B mir 29b regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3 |
10 | hsa-miR-3065-5p | AKT3 | -0.32 | 0.31142 | 0.2 | 0.64987 | mirMAP | -0.22 | 0 | NA | |
11 | hsa-miR-362-3p | AKT3 | 0.08 | 0.76325 | 0.2 | 0.64987 | miRanda | -0.25 | 0.00124 | NA | |
12 | hsa-miR-501-3p | AKT3 | -0.21 | 0.74913 | 0.2 | 0.64987 | miRNATAP | -0.18 | 0.00733 | NA | |
13 | hsa-miR-502-3p | AKT3 | -0.07 | 0.86362 | 0.2 | 0.64987 | miRNATAP | -0.23 | 0.03065 | NA | |
14 | hsa-miR-93-5p | AKT3 | -0.1 | 0.94883 | 0.2 | 0.64987 | miRNATAP | -0.33 | 0.00021 | NA | |
15 | hsa-miR-146b-5p | BRAF | 0.23 | 0.85357 | 0.03 | 0.93887 | miRanda | -0.1 | 0.0087 | 21874046; 26883911; 20406109; 21537871 | Additionally the activation of thyroid most common oncogenes RET/PTC3 and BRAF in PCCL3 cells upregulated miR-146b-5p expression;miR-146b-5p positively regulates migration and invasion of thyroid normal and tumor follicular cells independently from their original mutation either BRAF or RET/PTC through a mechanism that involves the actin cytoskeleton but not an increased capacity of matrix degradation;The miR-146b expression levels in PTCs with BRAF mutation were significantly higher than those without this mutation p < 0.0001;Among BRAF-positive tumors overexpression of miR-146b was associated with aggressive behavior suggesting that it may further refine the prognostic importance of BRAF |
16 | hsa-miR-200b-3p | CAB39 | 0.01 | 0.99556 | 0.13 | 0.8746 | MirTarget; TargetScan | -0.1 | 0.00021 | NA | |
17 | hsa-miR-155-5p | CAB39L | 0.15 | 0.89462 | 0.13 | 0.7531 | miRNAWalker2 validate | -0.24 | 0 | NA | |
18 | hsa-miR-33a-3p | CAB39L | 0.03 | 0.88794 | 0.13 | 0.7531 | MirTarget | -0.18 | 0.00143 | NA | |
19 | hsa-miR-342-3p | CAB39L | 0.15 | 0.86763 | 0.13 | 0.7531 | miRanda | -0.29 | 0 | NA | |
20 | hsa-miR-590-3p | CAB39L | -0.14 | 0.70045 | 0.13 | 0.7531 | miRanda | -0.31 | 2.0E-5 | NA | |
21 | hsa-miR-590-5p | CAB39L | -0.17 | 0.73474 | 0.13 | 0.7531 | miRanda | -0.25 | 0.00067 | NA | |
22 | hsa-miR-101-3p | DDIT4 | -0.02 | 0.99083 | -0.11 | 0.91449 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.23 | 0.00577 | NA | |
23 | hsa-miR-181c-5p | DDIT4 | 0.35 | 0.60937 | -0.11 | 0.91449 | MirTarget | -0.18 | 0.0295 | NA | |
24 | hsa-miR-200b-3p | DDIT4 | 0.01 | 0.99556 | -0.11 | 0.91449 | TargetScan | -0.15 | 0.00841 | NA | |
25 | hsa-miR-429 | DDIT4 | -0.2 | 0.8303 | -0.11 | 0.91449 | miRanda; miRNATAP | -0.12 | 0.02374 | NA | |
26 | hsa-miR-186-5p | EIF4E | -0.03 | 0.97568 | -0.15 | 0.81845 | mirMAP | -0.11 | 0.04871 | NA | |
27 | hsa-miR-30c-5p | EIF4E | 0.03 | 0.9773 | -0.15 | 0.81845 | mirMAP | -0.13 | 0.00522 | NA | |
28 | hsa-miR-125a-5p | EIF4EBP1 | 0.28 | 0.80489 | -0.3 | 0.71046 | miRNAWalker2 validate; MirTarget; miRanda; miRNATAP | -0.19 | 0.00177 | 26646586 | Increased expression of miR-125a and miR-125b inhibited invasion and migration of SKOV3 and OVCAR-429 ovarian cancer cells and was associated with a decrease in EIF4EBP1 expression |
29 | hsa-miR-195-3p | HIF1A | -0.08 | 0.73767 | 0.09 | 0.92799 | MirTarget | -0.12 | 0.01165 | NA | |
30 | hsa-miR-28-5p | HIF1A | 0.11 | 0.89598 | 0.09 | 0.92799 | miRanda | -0.25 | 0.00323 | NA | |
31 | hsa-miR-320c | HIF1A | 0.17 | 0.35539 | 0.09 | 0.92799 | miRanda | -0.11 | 0.04721 | NA | |
32 | hsa-miR-660-5p | HIF1A | -0.16 | 0.82202 | 0.09 | 0.92799 | MirTarget | -0.16 | 0.01701 | NA | |
33 | hsa-let-7a-3p | IGF1 | -0.06 | 0.93408 | 0.16 | 0.73859 | mirMAP | -0.41 | 0.03908 | NA | |
34 | hsa-let-7f-1-3p | IGF1 | 0.17 | 0.56684 | 0.16 | 0.73859 | mirMAP | -0.92 | 0 | NA | |
35 | hsa-miR-103a-2-5p | IGF1 | 0.06 | 0.82236 | 0.16 | 0.73859 | mirMAP | -0.61 | 0 | NA | |
36 | hsa-miR-130b-3p | IGF1 | -0.1 | 0.8629 | 0.16 | 0.73859 | MirTarget | -0.48 | 0.00036 | NA | |
37 | hsa-miR-15b-3p | IGF1 | -0.11 | 0.88561 | 0.16 | 0.73859 | mirMAP | -0.73 | 0 | NA | |
38 | hsa-miR-16-1-3p | IGF1 | -0.02 | 0.9564 | 0.16 | 0.73859 | mirMAP | -0.81 | 0 | NA | |
39 | hsa-miR-19a-3p | IGF1 | -0.02 | 0.98187 | 0.16 | 0.73859 | MirTarget | -0.58 | 0 | NA | |
40 | hsa-miR-19b-1-5p | IGF1 | 0.14 | 0.75549 | 0.16 | 0.73859 | mirMAP | -1.02 | 0 | NA | |
41 | hsa-miR-19b-3p | IGF1 | -0.02 | 0.9825 | 0.16 | 0.73859 | MirTarget | -0.83 | 0 | NA | |
42 | hsa-miR-20a-3p | IGF1 | 0.01 | 0.98963 | 0.16 | 0.73859 | mirMAP | -0.77 | 0 | NA | |
43 | hsa-miR-27a-3p | IGF1 | 0.09 | 0.95011 | 0.16 | 0.73859 | miRNAWalker2 validate; miRTarBase | -1.1 | 0 | NA | |
44 | hsa-miR-301a-3p | IGF1 | -0.1 | 0.82283 | 0.16 | 0.73859 | MirTarget | -0.46 | 0.00055 | NA | |
45 | hsa-miR-32-3p | IGF1 | 0.4 | 0.03721 | 0.16 | 0.73859 | mirMAP | -0.55 | 3.0E-5 | NA | |
46 | hsa-miR-320b | IGF1 | 0.1 | 0.81036 | 0.16 | 0.73859 | miRNATAP | -0.32 | 0.02393 | NA | |
47 | hsa-miR-33a-3p | IGF1 | 0.03 | 0.88794 | 0.16 | 0.73859 | MirTarget | -0.4 | 0.00118 | NA | |
48 | hsa-miR-452-5p | IGF1 | 0.17 | 0.86116 | 0.16 | 0.73859 | MirTarget; mirMAP | -0.29 | 0.00626 | NA | |
49 | hsa-miR-454-3p | IGF1 | 0.14 | 0.74549 | 0.16 | 0.73859 | MirTarget | -0.4 | 0.01817 | NA | |
50 | hsa-miR-486-5p | IGF1 | -0.27 | 0.76316 | 0.16 | 0.73859 | PITA; miRNATAP | -0.35 | 0 | NA | |
51 | hsa-miR-576-5p | IGF1 | 0.03 | 0.94567 | 0.16 | 0.73859 | PITA; mirMAP; miRNATAP | -0.69 | 4.0E-5 | NA | |
52 | hsa-miR-590-3p | IGF1 | -0.14 | 0.70045 | 0.16 | 0.73859 | MirTarget; miRanda; mirMAP; miRNATAP | -0.34 | 0.03163 | NA | |
53 | hsa-miR-629-5p | IGF1 | 0.32 | 0.7228 | 0.16 | 0.73859 | mirMAP | -0.43 | 0.0009 | NA | |
54 | hsa-miR-940 | IGF1 | -0.21 | 0.49157 | 0.16 | 0.73859 | MirTarget; PITA; miRNATAP | -0.34 | 0.00113 | NA | |
55 | hsa-miR-148b-3p | MAPK1 | -0.06 | 0.9484 | -0.07 | 0.94174 | mirMAP | -0.14 | 0.00442 | NA | |
56 | hsa-miR-29b-2-5p | MAPK1 | 0.05 | 0.91445 | -0.07 | 0.94174 | mirMAP | -0.15 | 2.0E-5 | NA | |
57 | hsa-miR-29c-3p | MAPK1 | -0.04 | 0.97819 | -0.07 | 0.94174 | mirMAP | -0.12 | 0 | NA | |
58 | hsa-miR-30b-5p | MAPK1 | 0.05 | 0.96125 | -0.07 | 0.94174 | mirMAP | -0.11 | 0.00754 | NA | |
59 | hsa-miR-30e-5p | MAPK1 | -0 | 0.99951 | -0.07 | 0.94174 | mirMAP | -0.12 | 0.00886 | NA | |
60 | hsa-miR-3913-5p | MAPK1 | -0.02 | 0.92975 | -0.07 | 0.94174 | mirMAP | -0.11 | 0.0044 | NA | |
61 | hsa-miR-2355-5p | PDPK1 | -0.03 | 0.96196 | -0.03 | 0.96799 | mirMAP | -0.1 | 0.00842 | NA | |
62 | hsa-miR-28-5p | PDPK1 | 0.11 | 0.89598 | -0.03 | 0.96799 | mirMAP | -0.15 | 0.03137 | NA | |
63 | hsa-miR-29a-3p | PDPK1 | 0.14 | 0.92846 | -0.03 | 0.96799 | mirMAP | -0.1 | 0.0215 | NA | |
64 | hsa-miR-320a | PDPK1 | 0.04 | 0.97287 | -0.03 | 0.96799 | miRanda | -0.12 | 0.01461 | NA | |
65 | hsa-miR-331-3p | PDPK1 | 0.08 | 0.89026 | -0.03 | 0.96799 | miRNAWalker2 validate | -0.12 | 0.00928 | NA | |
66 | hsa-miR-335-5p | PDPK1 | -0.09 | 0.82228 | -0.03 | 0.96799 | mirMAP | -0.12 | 0.0009 | NA | |
67 | hsa-miR-374a-3p | PDPK1 | -0.04 | 0.97734 | -0.03 | 0.96799 | mirMAP | -0.23 | 2.0E-5 | NA | |
68 | hsa-miR-374b-5p | PDPK1 | -0.12 | 0.87256 | -0.03 | 0.96799 | miRNATAP | -0.2 | 0.00228 | NA | |
69 | hsa-miR-424-5p | PDPK1 | 0.17 | 0.86176 | -0.03 | 0.96799 | mirMAP | -0.11 | 0.00322 | NA | |
70 | hsa-miR-505-3p | PDPK1 | 0.09 | 0.88836 | -0.03 | 0.96799 | mirMAP | -0.16 | 0.00135 | NA | |
71 | hsa-miR-542-3p | PDPK1 | 0.02 | 0.98096 | -0.03 | 0.96799 | mirMAP | -0.12 | 0.01595 | NA | |
72 | hsa-miR-590-3p | PDPK1 | -0.14 | 0.70045 | -0.03 | 0.96799 | miRanda; miRNATAP | -0.15 | 0.00127 | NA | |
73 | hsa-miR-628-5p | PDPK1 | 0.14 | 0.70237 | -0.03 | 0.96799 | PITA; miRNATAP | -0.12 | 0.02757 | NA | |
74 | hsa-miR-7-1-3p | PDPK1 | 0.09 | 0.87234 | -0.03 | 0.96799 | mirMAP | -0.17 | 0.00048 | NA | |
75 | hsa-miR-708-3p | PDPK1 | -0.03 | 0.97114 | -0.03 | 0.96799 | miRNATAP | -0.1 | 0.00176 | NA | |
76 | hsa-miR-34a-5p | PGF | -0.18 | 0.84619 | -0.48 | 0.38639 | miRNATAP | -0.47 | 0.00035 | NA | |
77 | hsa-miR-429 | PGF | -0.2 | 0.8303 | -0.48 | 0.38639 | miRNATAP | -0.26 | 0.0002 | NA | |
78 | hsa-miR-146b-5p | PIK3CA | 0.23 | 0.85357 | -0.02 | 0.97847 | mirMAP | -0.1 | 0.0215 | NA | |
79 | hsa-miR-148b-3p | PIK3CA | -0.06 | 0.9484 | -0.02 | 0.97847 | miRNAWalker2 validate | -0.24 | 0.00148 | NA | |
80 | hsa-miR-186-5p | PIK3CA | -0.03 | 0.97568 | -0.02 | 0.97847 | mirMAP | -0.28 | 0.00023 | NA | |
81 | hsa-miR-29b-1-5p | PIK3CA | 0.08 | 0.78872 | -0.02 | 0.97847 | mirMAP | -0.12 | 0.00234 | NA | |
82 | hsa-miR-320a | PIK3CA | 0.04 | 0.97287 | -0.02 | 0.97847 | miRanda | -0.13 | 0.01523 | NA | |
83 | hsa-miR-320b | PIK3CA | 0.1 | 0.81036 | -0.02 | 0.97847 | miRanda | -0.12 | 0.00551 | NA | |
84 | hsa-miR-335-5p | PIK3CA | -0.09 | 0.82228 | -0.02 | 0.97847 | miRNAWalker2 validate | -0.12 | 0.00088 | NA | |
85 | hsa-miR-338-5p | PIK3CA | -0.06 | 0.85281 | -0.02 | 0.97847 | mirMAP | -0.11 | 0.00047 | NA | |
86 | hsa-miR-339-5p | PIK3CA | -0.04 | 0.94751 | -0.02 | 0.97847 | miRanda | -0.14 | 0.00178 | NA | |
87 | hsa-miR-501-5p | PIK3CA | -0.03 | 0.91483 | -0.02 | 0.97847 | mirMAP | -0.12 | 0.00474 | NA | |
88 | hsa-miR-590-3p | PIK3CA | -0.14 | 0.70045 | -0.02 | 0.97847 | miRanda; mirMAP | -0.12 | 0.01336 | NA | |
89 | hsa-miR-130a-3p | PIK3CB | 0.47 | 0.58902 | -0.09 | 0.90347 | miRNATAP | -0.12 | 0.00106 | NA | |
90 | hsa-miR-19b-3p | PIK3CB | -0.02 | 0.9825 | -0.09 | 0.90347 | miRNATAP | -0.11 | 0.00639 | NA | |
91 | hsa-miR-1468-5p | PIK3CD | 0.08 | 0.78679 | 0.21 | 0.71819 | MirTarget | -0.15 | 0.0056 | NA | |
92 | hsa-miR-199a-5p | PIK3CD | -0.19 | 0.87328 | 0.21 | 0.71819 | MirTarget; PITA; miRanda; miRNATAP | -0.16 | 0.00086 | NA | |
93 | hsa-miR-30d-5p | PIK3CD | 0.01 | 0.99569 | 0.21 | 0.71819 | MirTarget; miRNATAP | -0.27 | 0.00723 | NA | |
94 | hsa-miR-324-5p | PIK3CD | -0 | 0.99456 | 0.21 | 0.71819 | miRanda | -0.17 | 0.01041 | NA | |
95 | hsa-miR-3913-5p | PIK3CD | -0.02 | 0.92975 | 0.21 | 0.71819 | mirMAP | -0.26 | 0.00117 | NA | |
96 | hsa-miR-335-3p | PIK3CG | 0.05 | 0.95617 | 0.09 | 0.72071 | mirMAP | -0.29 | 1.0E-5 | NA | |
97 | hsa-miR-502-5p | PIK3CG | -0.4 | 0.03714 | 0.09 | 0.72071 | miRNATAP | -0.17 | 0.02848 | 26163264 | Phosphoinositide 3-kinase catalytic subunit gamma PIK3CG was identified as a direct downstream target of miR-502 in HCC cells; Notably overexpression of PIK3CG reversed the inhibitory effects of miR-502 in HCC cells |
98 | hsa-miR-1301-3p | PIK3R1 | 0.22 | 0.63487 | -0.15 | 0.83268 | MirTarget | -0.14 | 0.04872 | NA | |
99 | hsa-miR-16-2-3p | PIK3R1 | -0.07 | 0.90793 | -0.15 | 0.83268 | MirTarget | -0.22 | 0.0055 | NA | |
100 | hsa-miR-16-5p | PIK3R1 | 0.01 | 0.99567 | -0.15 | 0.83268 | MirTarget | -0.23 | 0.00941 | NA | |
101 | hsa-miR-17-5p | PIK3R1 | -0 | 0.99959 | -0.15 | 0.83268 | MirTarget; TargetScan; miRNATAP | -0.26 | 0.00056 | NA | |
102 | hsa-miR-182-5p | PIK3R1 | -0.12 | 0.94487 | -0.15 | 0.83268 | miRNATAP | -0.12 | 0.02469 | NA | |
103 | hsa-miR-200c-3p | PIK3R1 | 0.1 | 0.95219 | -0.15 | 0.83268 | mirMAP | -0.21 | 0.00097 | NA | |
104 | hsa-miR-20a-5p | PIK3R1 | 0.01 | 0.99178 | -0.15 | 0.83268 | MirTarget; miRNATAP | -0.17 | 0.02326 | NA | |
105 | hsa-miR-21-5p | PIK3R1 | 0.1 | 0.9651 | -0.15 | 0.83268 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.3 | 0.01798 | 26676464 | PIK3R1 targeting by miR 21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT and predicts clinical outcome of breast cancer; Next we identified the PIK3R1 as a direct target of miR-21 and showed that it was negatively regulated by miR-21; Taken together we provide novel evidence that miR-21 knockdown suppresses cell growth migration and invasion partly by inhibiting PI3K/AKT activation via direct targeting PIK3R1 and reversing EMT in breast cancer |
106 | hsa-miR-22-5p | PIK3R1 | -0.01 | 0.98488 | -0.15 | 0.83268 | mirMAP | -0.17 | 0.0322 | NA | |
107 | hsa-miR-29a-3p | PIK3R1 | 0.14 | 0.92846 | -0.15 | 0.83268 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.16 | 0.03846 | NA | |
108 | hsa-miR-29b-3p | PIK3R1 | 0.14 | 0.9001 | -0.15 | 0.83268 | MirTarget; miRNATAP | -0.23 | 0.00248 | NA | |
109 | hsa-miR-3065-5p | PIK3R1 | -0.32 | 0.31142 | -0.15 | 0.83268 | MirTarget; mirMAP; miRNATAP | -0.14 | 0.003 | NA | |
110 | hsa-miR-32-3p | PIK3R1 | 0.4 | 0.03721 | -0.15 | 0.83268 | mirMAP | -0.16 | 0.0224 | NA | |
111 | hsa-miR-320b | PIK3R1 | 0.1 | 0.81036 | -0.15 | 0.83268 | miRNATAP | -0.18 | 0.01663 | NA | |
112 | hsa-miR-320c | PIK3R1 | 0.17 | 0.35539 | -0.15 | 0.83268 | miRNATAP | -0.24 | 0.00153 | NA | |
113 | hsa-miR-330-3p | PIK3R1 | -0.01 | 0.97039 | -0.15 | 0.83268 | MirTarget; PITA; miRNATAP | -0.22 | 0.00056 | NA | |
114 | hsa-miR-335-3p | PIK3R1 | 0.05 | 0.95617 | -0.15 | 0.83268 | mirMAP | -0.19 | 0.00155 | NA | |
115 | hsa-miR-338-5p | PIK3R1 | -0.06 | 0.85281 | -0.15 | 0.83268 | PITA | -0.15 | 0.00415 | NA | |
116 | hsa-miR-455-3p | PIK3R1 | 0.14 | 0.88975 | -0.15 | 0.83268 | MirTarget; PITA; miRNATAP | -0.15 | 0.01211 | NA | |
117 | hsa-miR-582-5p | PIK3R1 | 0.04 | 0.94537 | -0.15 | 0.83268 | mirMAP | -0.17 | 0.00029 | NA | |
118 | hsa-miR-584-5p | PIK3R1 | 0.19 | 0.80357 | -0.15 | 0.83268 | mirMAP | -0.26 | 0 | NA | |
119 | hsa-miR-590-3p | PIK3R1 | -0.14 | 0.70045 | -0.15 | 0.83268 | miRanda; mirMAP | -0.19 | 0.02377 | NA | |
120 | hsa-miR-590-5p | PIK3R1 | -0.17 | 0.73474 | -0.15 | 0.83268 | MirTarget; PITA; miRanda; miRNATAP | -0.3 | 0.00045 | NA | |
121 | hsa-miR-629-3p | PIK3R1 | 0.26 | 0.47908 | -0.15 | 0.83268 | MirTarget | -0.21 | 0.00106 | NA | |
122 | hsa-miR-1271-5p | PIK3R3 | 0.11 | 0.66464 | 0.01 | 0.98958 | mirMAP | -0.15 | 0.003 | NA | |
123 | hsa-miR-18a-3p | PIK3R3 | 0.05 | 0.8491 | 0.01 | 0.98958 | miRNAWalker2 validate | -0.17 | 9.0E-5 | NA | |
124 | hsa-miR-19b-3p | PIK3R3 | -0.02 | 0.9825 | 0.01 | 0.98958 | MirTarget; miRNATAP | -0.13 | 0.0429 | NA | |
125 | hsa-miR-222-5p | PIK3R3 | 0.33 | 0.48974 | 0.01 | 0.98958 | mirMAP | -0.17 | 4.0E-5 | NA | |
126 | hsa-miR-26b-5p | PIK3R3 | -0.01 | 0.99661 | 0.01 | 0.98958 | miRNATAP | -0.16 | 0.03892 | NA | |
127 | hsa-miR-29b-1-5p | PIK3R3 | 0.08 | 0.78872 | 0.01 | 0.98958 | mirMAP | -0.21 | 3.0E-5 | NA | |
128 | hsa-miR-32-5p | PIK3R3 | 0.06 | 0.92649 | 0.01 | 0.98958 | MirTarget; miRNATAP | -0.16 | 0.01912 | NA | |
129 | hsa-miR-330-3p | PIK3R3 | -0.01 | 0.97039 | 0.01 | 0.98958 | MirTarget | -0.19 | 0.00014 | NA | |
130 | hsa-miR-330-5p | PIK3R3 | 0.01 | 0.98832 | 0.01 | 0.98958 | miRanda | -0.16 | 0.00263 | NA | |
131 | hsa-miR-335-3p | PIK3R3 | 0.05 | 0.95617 | 0.01 | 0.98958 | mirMAP | -0.1 | 0.02543 | NA | |
132 | hsa-miR-365a-3p | PIK3R3 | -0.02 | 0.9772 | 0.01 | 0.98958 | MirTarget | -0.33 | 0 | NA | |
133 | hsa-miR-511-5p | PIK3R3 | 0.16 | 0.68017 | 0.01 | 0.98958 | MirTarget | -0.18 | 1.0E-5 | 25608840 | MiR 511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3; We further demonstrated that miR-511 suppressed HCC cell proliferation migration and invasion by repressing PIK3R3 expression |
134 | hsa-miR-590-3p | PIK3R3 | -0.14 | 0.70045 | 0.01 | 0.98958 | PITA; mirMAP; miRNATAP | -0.14 | 0.03743 | NA | |
135 | hsa-miR-590-5p | PIK3R3 | -0.17 | 0.73474 | 0.01 | 0.98958 | miRanda | -0.2 | 0.00312 | NA | |
136 | hsa-miR-92a-3p | PIK3R3 | 0.03 | 0.98479 | 0.01 | 0.98958 | MirTarget; miRNATAP | -0.18 | 0.01743 | NA | |
137 | hsa-miR-125a-3p | PIK3R5 | 0.12 | 0.75291 | 0.07 | 0.85282 | miRanda | -0.14 | 0.00747 | NA | |
138 | hsa-miR-125a-5p | PIK3R5 | 0.28 | 0.80489 | 0.07 | 0.85282 | MirTarget; miRanda | -0.25 | 0.00223 | NA | |
139 | hsa-miR-182-5p | PIK3R5 | -0.12 | 0.94487 | 0.07 | 0.85282 | MirTarget | -0.25 | 0 | NA | |
140 | hsa-let-7a-3p | PRKAA1 | -0.06 | 0.93408 | 0.09 | 0.90484 | MirTarget; mirMAP | -0.1 | 0.04882 | NA | |
141 | hsa-miR-146b-3p | PRKAA1 | 0.32 | 0.7171 | 0.09 | 0.90484 | MirTarget; PITA; miRNATAP | -0.1 | 0.01404 | NA | |
142 | hsa-miR-19a-3p | PRKAA1 | -0.02 | 0.98187 | 0.09 | 0.90484 | miRNATAP | -0.12 | 0.00012 | NA | |
143 | hsa-miR-19b-3p | PRKAA1 | -0.02 | 0.9825 | 0.09 | 0.90484 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.14 | 0.00076 | NA | |
144 | hsa-miR-30e-5p | PRKAA1 | -0 | 0.99951 | 0.09 | 0.90484 | miRNAWalker2 validate | -0.13 | 0.0245 | NA | |
145 | hsa-miR-590-3p | PRKAA1 | -0.14 | 0.70045 | 0.09 | 0.90484 | MirTarget; miRanda; mirMAP | -0.16 | 0.00015 | NA | |
146 | hsa-miR-590-5p | PRKAA1 | -0.17 | 0.73474 | 0.09 | 0.90484 | miRanda | -0.13 | 0.00313 | NA | |
147 | hsa-miR-664a-3p | PRKAA1 | 0.04 | 0.94126 | 0.09 | 0.90484 | mirMAP | -0.1 | 0.04303 | NA | |
148 | hsa-let-7f-1-3p | PRKAA2 | 0.17 | 0.56684 | 0.39 | 0.45499 | mirMAP | -0.46 | 0.01765 | NA | |
149 | hsa-let-7i-5p | PRKAA2 | 0.04 | 0.97484 | 0.39 | 0.45499 | MirTarget | -0.81 | 0.01294 | NA | |
150 | hsa-miR-142-5p | PRKAA2 | -0.02 | 0.97761 | 0.39 | 0.45499 | mirMAP | -0.73 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHORYLATION | 25 | 1228 | 1.252e-22 | 5.827e-19 |
2 | PROTEIN PHOSPHORYLATION | 23 | 944 | 3.144e-22 | 7.315e-19 |
3 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 26 | 1977 | 6.041e-19 | 9.369e-16 |
4 | INTRACELLULAR SIGNAL TRANSDUCTION | 24 | 1572 | 1.301e-18 | 1.513e-15 |
5 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 22 | 1618 | 1.033e-15 | 9.611e-13 |
6 | INOSITOL LIPID MEDIATED SIGNALING | 10 | 124 | 1.287e-14 | 9.98e-12 |
7 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 17 | 1036 | 4.138e-13 | 2.407e-10 |
8 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 17 | 1036 | 4.138e-13 | 2.407e-10 |
9 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 21 | 1929 | 5.639e-13 | 2.916e-10 |
10 | REGULATION OF KINASE ACTIVITY | 15 | 776 | 1.549e-12 | 7.209e-10 |
11 | PEPTIDYL SERINE MODIFICATION | 9 | 148 | 4.134e-12 | 1.603e-09 |
12 | PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 6 | 25 | 3.79e-12 | 1.603e-09 |
13 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 19 | 1656 | 5.474e-12 | 1.959e-09 |
14 | CELL ACTIVATION | 13 | 568 | 8.667e-12 | 2.88e-09 |
15 | NEGATIVE REGULATION OF TOR SIGNALING | 6 | 30 | 1.262e-11 | 3.916e-09 |
16 | POSITIVE REGULATION OF KINASE ACTIVITY | 12 | 482 | 2.481e-11 | 7.129e-09 |
17 | REGULATION OF TRANSFERASE ACTIVITY | 15 | 946 | 2.605e-11 | 7.129e-09 |
18 | REGULATION OF TOR SIGNALING | 7 | 68 | 2.952e-11 | 7.631e-09 |
19 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 12 | 498 | 3.622e-11 | 8.87e-09 |
20 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 10 | 279 | 4.387e-11 | 1.021e-08 |
21 | RESPONSE TO PEPTIDE | 11 | 404 | 7.619e-11 | 1.641e-08 |
22 | RESPONSE TO INSULIN | 9 | 205 | 7.76e-11 | 1.641e-08 |
23 | REGULATION OF PROTEIN MODIFICATION PROCESS | 18 | 1710 | 1.109e-10 | 2.244e-08 |
24 | CELLULAR RESPONSE TO HORMONE STIMULUS | 12 | 552 | 1.188e-10 | 2.302e-08 |
25 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 17 | 1492 | 1.377e-10 | 2.563e-08 |
26 | RESPONSE TO HORMONE | 14 | 893 | 1.716e-10 | 3.071e-08 |
27 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 6 | 49 | 2.901e-10 | 5e-08 |
28 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 15 | 1135 | 3.356e-10 | 5.577e-08 |
29 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 12 | 616 | 4.171e-10 | 6.693e-08 |
30 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 16 | 1381 | 4.777e-10 | 7.409e-08 |
31 | RESPONSE TO ABIOTIC STIMULUS | 14 | 1024 | 1.027e-09 | 1.542e-07 |
32 | REGULATION OF CELL DEATH | 16 | 1472 | 1.217e-09 | 1.769e-07 |
33 | RESPONSE TO NITROGEN COMPOUND | 13 | 859 | 1.428e-09 | 2.013e-07 |
34 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 12 | 689 | 1.489e-09 | 2.038e-07 |
35 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 13 | 867 | 1.598e-09 | 2.097e-07 |
36 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 289 | 1.622e-09 | 2.097e-07 |
37 | PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 7 | 120 | 1.695e-09 | 2.097e-07 |
38 | NEGATIVE REGULATION OF CELL DEATH | 13 | 872 | 1.713e-09 | 2.097e-07 |
39 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 74 | 3.722e-09 | 4.44e-07 |
40 | POSITIVE REGULATION OF AUTOPHAGY | 6 | 75 | 4.04e-09 | 4.7e-07 |
41 | REGULATION OF CELL CYCLE | 13 | 949 | 4.759e-09 | 5.401e-07 |
42 | REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 5 | 36 | 5.123e-09 | 5.675e-07 |
43 | PLATELET ACTIVATION | 7 | 142 | 5.508e-09 | 5.961e-07 |
44 | CELLULAR RESPONSE TO INSULIN STIMULUS | 7 | 146 | 6.685e-09 | 6.912e-07 |
45 | T CELL RECEPTOR SIGNALING PATHWAY | 7 | 146 | 6.685e-09 | 6.912e-07 |
46 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 10 | 470 | 6.865e-09 | 6.944e-07 |
47 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 12 | 799 | 7.871e-09 | 7.772e-07 |
48 | REGULATION OF CELL ADHESION | 11 | 629 | 8.018e-09 | 7.772e-07 |
49 | CELL CYCLE ARREST | 7 | 154 | 9.686e-09 | 8.778e-07 |
50 | RESPONSE TO ENDOGENOUS STIMULUS | 15 | 1450 | 9.718e-09 | 8.778e-07 |
51 | REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 9 | 354 | 9.518e-09 | 8.778e-07 |
52 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 13 | 1008 | 9.81e-09 | 8.778e-07 |
53 | REGULATION OF AUTOPHAGY | 8 | 249 | 1.155e-08 | 9.599e-07 |
54 | REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS | 5 | 42 | 1.147e-08 | 9.599e-07 |
55 | REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 6 | 89 | 1.145e-08 | 9.599e-07 |
56 | REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 5 | 42 | 1.147e-08 | 9.599e-07 |
57 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 10 | 505 | 1.359e-08 | 1.109e-06 |
58 | POSITIVE REGULATION OF CELL ADHESION | 9 | 376 | 1.603e-08 | 1.265e-06 |
59 | TOR SIGNALING | 4 | 16 | 1.584e-08 | 1.265e-06 |
60 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 15 | 1518 | 1.805e-08 | 1.4e-06 |
61 | GLUCOSE HOMEOSTASIS | 7 | 170 | 1.921e-08 | 1.442e-06 |
62 | CARBOHYDRATE HOMEOSTASIS | 7 | 170 | 1.921e-08 | 1.442e-06 |
63 | POSITIVE REGULATION OF CELL COMMUNICATION | 15 | 1532 | 2.042e-08 | 1.481e-06 |
64 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 16 | 1791 | 2.061e-08 | 1.481e-06 |
65 | POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS | 4 | 17 | 2.069e-08 | 1.481e-06 |
66 | LIPID PHOSPHORYLATION | 6 | 99 | 2.18e-08 | 1.537e-06 |
67 | CELLULAR RESPONSE TO PEPTIDE | 8 | 274 | 2.432e-08 | 1.689e-06 |
68 | REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 5 | 49 | 2.548e-08 | 1.718e-06 |
69 | REGULATION OF ATP METABOLIC PROCESS | 5 | 49 | 2.548e-08 | 1.718e-06 |
70 | RESPONSE TO EXTERNAL STIMULUS | 16 | 1821 | 2.611e-08 | 1.735e-06 |
71 | CELLULAR RESPONSE TO STRESS | 15 | 1565 | 2.72e-08 | 1.782e-06 |
72 | REGULATION OF COENZYME METABOLIC PROCESS | 5 | 50 | 2.827e-08 | 1.802e-06 |
73 | REGULATION OF COFACTOR METABOLIC PROCESS | 5 | 50 | 2.827e-08 | 1.802e-06 |
74 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 16 | 1848 | 3.217e-08 | 2.023e-06 |
75 | RESPONSE TO WOUNDING | 10 | 563 | 3.794e-08 | 2.323e-06 |
76 | REGULATION OF CATABOLIC PROCESS | 11 | 731 | 3.76e-08 | 2.323e-06 |
77 | PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 7 | 193 | 4.604e-08 | 2.782e-06 |
78 | ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 7 | 195 | 4.941e-08 | 2.948e-06 |
79 | NEGATIVE REGULATION OF CELL CYCLE | 9 | 433 | 5.393e-08 | 3.176e-06 |
80 | REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 6 | 118 | 6.255e-08 | 3.638e-06 |
81 | RESPONSE TO OXYGEN LEVELS | 8 | 311 | 6.475e-08 | 3.72e-06 |
82 | REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 5 | 59 | 6.604e-08 | 3.747e-06 |
83 | REGULATION OF GLUCOSE IMPORT | 5 | 60 | 7.195e-08 | 4.033e-06 |
84 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 11 | 788 | 8.074e-08 | 4.42e-06 |
85 | CIRCULATORY SYSTEM DEVELOPMENT | 11 | 788 | 8.074e-08 | 4.42e-06 |
86 | LIPID MODIFICATION | 7 | 210 | 8.208e-08 | 4.441e-06 |
87 | GLYCEROLIPID BIOSYNTHETIC PROCESS | 7 | 211 | 8.479e-08 | 4.535e-06 |
88 | IMMUNE SYSTEM PROCESS | 16 | 1984 | 8.754e-08 | 4.628e-06 |
89 | POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS | 4 | 24 | 9.154e-08 | 4.733e-06 |
90 | POSITIVE REGULATION OF ATP METABOLIC PROCESS | 4 | 24 | 9.154e-08 | 4.733e-06 |
91 | VASCULATURE DEVELOPMENT | 9 | 469 | 1.065e-07 | 5.447e-06 |
92 | WOUND HEALING | 9 | 470 | 1.085e-07 | 5.487e-06 |
93 | CELL MOTILITY | 11 | 835 | 1.45e-07 | 7.103e-06 |
94 | LOCALIZATION OF CELL | 11 | 835 | 1.45e-07 | 7.103e-06 |
95 | IMMUNE EFFECTOR PROCESS | 9 | 486 | 1.441e-07 | 7.103e-06 |
96 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 13 | 1275 | 1.569e-07 | 7.603e-06 |
97 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 6 | 138 | 1.59e-07 | 7.625e-06 |
98 | PHOSPHOLIPID BIOSYNTHETIC PROCESS | 7 | 235 | 1.766e-07 | 8.385e-06 |
99 | REGULATION OF BODY FLUID LEVELS | 9 | 506 | 2.027e-07 | 9.528e-06 |
100 | CELL CYCLE | 13 | 1316 | 2.264e-07 | 1.054e-05 |
101 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 6 | 154 | 3.042e-07 | 1.388e-05 |
102 | LOCOMOTION | 12 | 1114 | 3.026e-07 | 1.388e-05 |
103 | LIPID BIOSYNTHETIC PROCESS | 9 | 539 | 3.452e-07 | 1.559e-05 |
104 | AUTOPHAGY | 8 | 394 | 3.946e-07 | 1.749e-05 |
105 | PROTEIN KINASE B SIGNALING | 4 | 34 | 3.944e-07 | 1.749e-05 |
106 | REGULATION OF IMMUNE SYSTEM PROCESS | 13 | 1403 | 4.734e-07 | 2.078e-05 |
107 | REGULATION OF CELL MATRIX ADHESION | 5 | 90 | 5.569e-07 | 2.422e-05 |
108 | REGULATION OF LIPID METABOLIC PROCESS | 7 | 282 | 6.051e-07 | 2.583e-05 |
109 | REGULATION OF CELL SUBSTRATE ADHESION | 6 | 173 | 6.032e-07 | 2.583e-05 |
110 | NEGATIVE REGULATION OF CELL COMMUNICATION | 12 | 1192 | 6.25e-07 | 2.644e-05 |
111 | POSITIVE REGULATION OF LOCOMOTION | 8 | 420 | 6.396e-07 | 2.681e-05 |
112 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 7 | 285 | 6.496e-07 | 2.699e-05 |
113 | IMMUNE SYSTEM DEVELOPMENT | 9 | 582 | 6.563e-07 | 2.702e-05 |
114 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 10 | 771 | 6.991e-07 | 2.854e-05 |
115 | ACTIVATION OF IMMUNE RESPONSE | 8 | 427 | 7.244e-07 | 2.931e-05 |
116 | LEUKOCYTE DIFFERENTIATION | 7 | 292 | 7.644e-07 | 3.066e-05 |
117 | ANGIOGENESIS | 7 | 293 | 7.821e-07 | 3.11e-05 |
118 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 7 | 296 | 8.373e-07 | 3.302e-05 |
119 | GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 7 | 297 | 8.564e-07 | 3.349e-05 |
120 | CELL DEATH | 11 | 1001 | 8.848e-07 | 3.431e-05 |
121 | REGULATION OF GLUCOSE TRANSPORT | 5 | 100 | 9.418e-07 | 3.622e-05 |
122 | REGULATION OF CELL PROLIFERATION | 13 | 1496 | 9.847e-07 | 3.756e-05 |
123 | POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 8 | 448 | 1.039e-06 | 3.93e-05 |
124 | HEMOSTASIS | 7 | 311 | 1.165e-06 | 4.372e-05 |
125 | REGULATION OF TRANSPORT | 14 | 1804 | 1.264e-06 | 4.706e-05 |
126 | REGULATION OF MAP KINASE ACTIVITY | 7 | 319 | 1.38e-06 | 5.096e-05 |
127 | POSITIVE REGULATION OF MAPK CASCADE | 8 | 470 | 1.487e-06 | 5.449e-05 |
128 | IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 7 | 323 | 1.499e-06 | 5.45e-05 |
129 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 6 | 207 | 1.719e-06 | 6.2e-05 |
130 | LYMPHOCYTE DIFFERENTIATION | 6 | 209 | 1.818e-06 | 6.505e-05 |
131 | REGULATION OF MAPK CASCADE | 9 | 660 | 1.861e-06 | 6.612e-05 |
132 | CELL CYCLE PROCESS | 11 | 1081 | 1.881e-06 | 6.632e-05 |
133 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 6 | 211 | 1.921e-06 | 6.72e-05 |
134 | CHEMICAL HOMEOSTASIS | 10 | 874 | 2.176e-06 | 7.552e-05 |
135 | LYMPHOCYTE ACTIVATION | 7 | 342 | 2.191e-06 | 7.552e-05 |
136 | T CELL DIFFERENTIATION | 5 | 123 | 2.624e-06 | 8.976e-05 |
137 | GLYCEROLIPID METABOLIC PROCESS | 7 | 356 | 2.857e-06 | 9.703e-05 |
138 | PHOSPHOLIPID METABOLIC PROCESS | 7 | 364 | 3.308e-06 | 0.0001107 |
139 | BLOOD VESSEL MORPHOGENESIS | 7 | 364 | 3.308e-06 | 0.0001107 |
140 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 13 | 1672 | 3.439e-06 | 0.0001143 |
141 | REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 3 | 17 | 3.579e-06 | 0.0001181 |
142 | POSITIVE REGULATION OF GENE EXPRESSION | 13 | 1733 | 5.118e-06 | 0.0001677 |
143 | FC EPSILON RECEPTOR SIGNALING PATHWAY | 5 | 142 | 5.309e-06 | 0.0001727 |
144 | REGULATION OF NEURON DEATH | 6 | 252 | 5.349e-06 | 0.0001728 |
145 | CELLULAR RESPONSE TO OXYGEN LEVELS | 5 | 143 | 5.494e-06 | 0.0001763 |
146 | REGULATION OF RESPONSE TO STRESS | 12 | 1468 | 5.569e-06 | 0.0001775 |
147 | POSITIVE REGULATION OF CATABOLIC PROCESS | 7 | 395 | 5.66e-06 | 0.000178 |
148 | POSITIVE REGULATION OF IMMUNE RESPONSE | 8 | 563 | 5.662e-06 | 0.000178 |
149 | LEUKOCYTE CELL CELL ADHESION | 6 | 255 | 5.725e-06 | 0.0001788 |
150 | LEUKOCYTE MIGRATION | 6 | 259 | 6.258e-06 | 0.0001941 |
151 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 68 | 6.631e-06 | 0.0002043 |
152 | POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 3 | 21 | 6.966e-06 | 0.0002132 |
153 | RESPONSE TO ACTIVITY | 4 | 69 | 7.031e-06 | 0.0002138 |
154 | LEUKOCYTE ACTIVATION | 7 | 414 | 7.693e-06 | 0.0002324 |
155 | RESPONSE TO PURINE CONTAINING COMPOUND | 5 | 158 | 8.933e-06 | 0.0002682 |
156 | POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 4 | 75 | 9.809e-06 | 0.0002926 |
157 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 162 | 1.009e-05 | 0.0002989 |
158 | POSITIVE REGULATION OF CELL PROLIFERATION | 9 | 814 | 1.025e-05 | 0.0003019 |
159 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 7 | 437 | 1.094e-05 | 0.00032 |
160 | LYMPHOCYTE COSTIMULATION | 4 | 78 | 1.147e-05 | 0.0003335 |
161 | RESPONSE TO EXTRACELLULAR STIMULUS | 7 | 441 | 1.16e-05 | 0.0003353 |
162 | ERBB SIGNALING PATHWAY | 4 | 79 | 1.206e-05 | 0.0003465 |
163 | INSULIN RECEPTOR SIGNALING PATHWAY | 4 | 80 | 1.268e-05 | 0.000362 |
164 | ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 450 | 1.322e-05 | 0.0003732 |
165 | REGULATION OF GROWTH | 8 | 633 | 1.331e-05 | 0.0003732 |
166 | PEPTIDYL AMINO ACID MODIFICATION | 9 | 841 | 1.332e-05 | 0.0003732 |
167 | REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 5 | 172 | 1.348e-05 | 0.0003756 |
168 | SINGLE ORGANISM CELL ADHESION | 7 | 459 | 1.503e-05 | 0.0004162 |
169 | REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 27 | 1.521e-05 | 0.0004187 |
170 | REGULATION OF NEUROBLAST PROLIFERATION | 3 | 28 | 1.701e-05 | 0.0004629 |
171 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 11 | 1360 | 1.7e-05 | 0.0004629 |
172 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 9 | 876 | 1.843e-05 | 0.0004985 |
173 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 10 | 1142 | 2.301e-05 | 0.0006153 |
174 | PROTEIN AUTOPHOSPHORYLATION | 5 | 192 | 2.291e-05 | 0.0006153 |
175 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 3 | 31 | 2.325e-05 | 0.0006183 |
176 | FC GAMMA RECEPTOR SIGNALING PATHWAY | 4 | 95 | 2.504e-05 | 0.0006546 |
177 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 10 | 1152 | 2.481e-05 | 0.0006546 |
178 | REGULATION OF CELLULAR RESPONSE TO STRESS | 8 | 691 | 2.502e-05 | 0.0006546 |
179 | CELLULAR LIPID METABOLIC PROCESS | 9 | 913 | 2.557e-05 | 0.0006648 |
180 | CELL DEVELOPMENT | 11 | 1426 | 2.648e-05 | 0.0006846 |
181 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 4 | 98 | 2.831e-05 | 0.0007277 |
182 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 9 | 926 | 2.859e-05 | 0.0007309 |
183 | POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 4 | 99 | 2.946e-05 | 0.0007491 |
184 | FC RECEPTOR SIGNALING PATHWAY | 5 | 206 | 3.211e-05 | 0.0008119 |
185 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 9 | 957 | 3.703e-05 | 0.0009315 |
186 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 5 | 213 | 3.766e-05 | 0.0009422 |
187 | REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 37 | 3.99e-05 | 0.0009928 |
188 | REGULATION OF CELL DIFFERENTIATION | 11 | 1492 | 4.029e-05 | 0.0009971 |
189 | CELL CYCLE G1 S PHASE TRANSITION | 4 | 111 | 4.616e-05 | 0.00113 |
190 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 4 | 111 | 4.616e-05 | 0.00113 |
191 | REGULATED EXOCYTOSIS | 5 | 224 | 4.787e-05 | 0.001166 |
192 | TUBE DEVELOPMENT | 7 | 552 | 4.89e-05 | 0.001185 |
193 | PROTEIN HETEROOLIGOMERIZATION | 4 | 113 | 4.95e-05 | 0.001193 |
194 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 3 | 40 | 5.055e-05 | 0.001206 |
195 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 3 | 40 | 5.055e-05 | 0.001206 |
196 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 8 | 767 | 5.256e-05 | 0.001248 |
197 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 5 | 229 | 5.317e-05 | 0.001256 |
198 | SINGLE ORGANISM BEHAVIOR | 6 | 384 | 5.764e-05 | 0.001355 |
199 | POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 3 | 42 | 5.859e-05 | 0.001363 |
200 | POSITIVE REGULATION OF GLUCOSE TRANSPORT | 3 | 42 | 5.859e-05 | 0.001363 |
201 | RESPONSE TO ELECTRICAL STIMULUS | 3 | 43 | 6.29e-05 | 0.001456 |
202 | REGULATION OF PROTEIN KINASE B SIGNALING | 4 | 121 | 6.464e-05 | 0.001489 |
203 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 4 | 123 | 6.89e-05 | 0.001579 |
204 | POSITIVE REGULATION OF CELL CELL ADHESION | 5 | 243 | 7.043e-05 | 0.001606 |
205 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 8 | 801 | 7.132e-05 | 0.001619 |
206 | DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 7 | 602 | 8.44e-05 | 0.001906 |
207 | HOMEOSTATIC PROCESS | 10 | 1337 | 8.799e-05 | 0.001941 |
208 | NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS | 4 | 131 | 8.802e-05 | 0.001941 |
209 | REGULATION OF LIPID KINASE ACTIVITY | 3 | 48 | 8.762e-05 | 0.001941 |
210 | POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 3 | 48 | 8.762e-05 | 0.001941 |
211 | POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS | 3 | 48 | 8.762e-05 | 0.001941 |
212 | CELL CELL ADHESION | 7 | 608 | 8.98e-05 | 0.001971 |
213 | POSITIVE REGULATION OF CELL DIVISION | 4 | 132 | 9.065e-05 | 0.00198 |
214 | POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS | 4 | 133 | 9.334e-05 | 0.002011 |
215 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 4 | 133 | 9.334e-05 | 0.002011 |
216 | POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 4 | 133 | 9.334e-05 | 0.002011 |
217 | REGULATION OF CELL DEVELOPMENT | 8 | 836 | 9.618e-05 | 0.002062 |
218 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 5 | 263 | 0.0001022 | 0.002182 |
219 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 5 | 264 | 0.0001041 | 0.002211 |
220 | RESPONSE TO DRUG | 6 | 431 | 0.0001089 | 0.002303 |
221 | CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 4 | 139 | 0.0001107 | 0.002331 |
222 | REGULATION OF IMMUNE RESPONSE | 8 | 858 | 0.0001152 | 0.002415 |
223 | NEURON PROJECTION EXTENSION | 3 | 53 | 0.0001179 | 0.002461 |
224 | REGULATION OF CELL DIVISION | 5 | 272 | 0.0001197 | 0.002487 |
225 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 3 | 54 | 0.0001247 | 0.002579 |
226 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 10 | 1395 | 0.0001254 | 0.002581 |
227 | NEUROGENESIS | 10 | 1402 | 0.0001307 | 0.002679 |
228 | EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 3 | 55 | 0.0001318 | 0.002689 |
229 | RESPONSE TO LIGHT STIMULUS | 5 | 280 | 0.0001371 | 0.002786 |
230 | EMBRYO DEVELOPMENT | 8 | 894 | 0.0001531 | 0.003097 |
231 | REGULATION OF DEVELOPMENTAL GROWTH | 5 | 289 | 0.0001589 | 0.003191 |
232 | REGULATION OF VESICLE MEDIATED TRANSPORT | 6 | 462 | 0.0001591 | 0.003191 |
233 | LIPID METABOLIC PROCESS | 9 | 1158 | 0.000161 | 0.003215 |
234 | TAXIS | 6 | 464 | 0.0001629 | 0.003238 |
235 | RESPONSE TO STARVATION | 4 | 154 | 0.0001644 | 0.003255 |
236 | POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 3 | 60 | 0.0001708 | 0.003367 |
237 | REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 3 | 61 | 0.0001794 | 0.003508 |
238 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 3 | 61 | 0.0001794 | 0.003508 |
239 | REGULATION OF ORGANELLE ORGANIZATION | 9 | 1178 | 0.0001833 | 0.003568 |
240 | RESPONSE TO OSMOTIC STRESS | 3 | 63 | 0.0001975 | 0.003828 |
241 | FATTY ACID HOMEOSTASIS | 2 | 12 | 0.0002056 | 0.003952 |
242 | POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS | 2 | 12 | 0.0002056 | 0.003952 |
243 | REGULATION OF HOMOTYPIC CELL CELL ADHESION | 5 | 307 | 0.0002105 | 0.00403 |
244 | REGULATION OF EPITHELIAL CELL MIGRATION | 4 | 166 | 0.0002192 | 0.004179 |
245 | EXOCYTOSIS | 5 | 310 | 0.0002202 | 0.004182 |
246 | POSITIVE REGULATION OF CELL ACTIVATION | 5 | 311 | 0.0002235 | 0.004227 |
247 | RESPONSE TO CARBOHYDRATE | 4 | 168 | 0.0002294 | 0.004304 |
248 | REGULATION OF AXONOGENESIS | 4 | 168 | 0.0002294 | 0.004304 |
249 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 3 | 67 | 0.000237 | 0.004412 |
250 | CELLULAR RESPONSE TO DRUG | 3 | 67 | 0.000237 | 0.004412 |
251 | REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 4 | 171 | 0.0002455 | 0.004497 |
252 | INDUCTION OF POSITIVE CHEMOTAXIS | 2 | 13 | 0.0002427 | 0.004497 |
253 | REGULATION OF RESPONSE TO NUTRIENT LEVELS | 4 | 171 | 0.0002455 | 0.004497 |
254 | NEGATIVE REGULATION OF NEURON DEATH | 4 | 171 | 0.0002455 | 0.004497 |
255 | REGULATION OF CELL SIZE | 4 | 172 | 0.000251 | 0.00458 |
256 | POSITIVE REGULATION OF AXONOGENESIS | 3 | 69 | 0.0002586 | 0.004684 |
257 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 5 | 321 | 0.0002587 | 0.004684 |
258 | VESICLE MEDIATED TRANSPORT | 9 | 1239 | 0.0002677 | 0.004827 |
259 | CELLULAR RESPONSE TO ELECTRICAL STIMULUS | 2 | 14 | 0.0002828 | 0.005003 |
260 | REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 2 | 14 | 0.0002828 | 0.005003 |
261 | INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 14 | 0.0002828 | 0.005003 |
262 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 6 | 513 | 0.00028 | 0.005003 |
263 | T CELL MIGRATION | 2 | 14 | 0.0002828 | 0.005003 |
264 | BEHAVIOR | 6 | 516 | 0.0002889 | 0.005092 |
265 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 8 | 983 | 0.0002928 | 0.00514 |
266 | REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 3 | 73 | 0.0003055 | 0.005344 |
267 | CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 3 | 74 | 0.000318 | 0.005542 |
268 | REGULATION OF CELLULAR COMPONENT SIZE | 5 | 337 | 0.0003236 | 0.005619 |
269 | RESPIRATORY BURST | 2 | 15 | 0.0003259 | 0.005638 |
270 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 7 | 750 | 0.0003272 | 0.005638 |
271 | GRANULOCYTE MIGRATION | 3 | 75 | 0.0003308 | 0.00566 |
272 | CELLULAR GLUCOSE HOMEOSTASIS | 3 | 75 | 0.0003308 | 0.00566 |
273 | REGULATION OF CELLULAR LOCALIZATION | 9 | 1277 | 0.0003351 | 0.005712 |
274 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 4 | 188 | 0.000352 | 0.005978 |
275 | REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 3 | 77 | 0.0003575 | 0.006027 |
276 | DEVELOPMENTAL CELL GROWTH | 3 | 77 | 0.0003575 | 0.006027 |
277 | PHAGOCYTOSIS | 4 | 190 | 0.0003665 | 0.006156 |
278 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 2 | 16 | 0.0003721 | 0.006227 |
279 | REPRODUCTION | 9 | 1297 | 0.0003759 | 0.00627 |
280 | DEVELOPMENTAL MATURATION | 4 | 193 | 0.0003889 | 0.006462 |
281 | NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 3 | 80 | 0.0004001 | 0.006625 |
282 | BIOLOGICAL ADHESION | 8 | 1032 | 0.0004063 | 0.006704 |
283 | NUCLEAR TRANSPORT | 5 | 355 | 0.0004108 | 0.006754 |
284 | POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING | 3 | 81 | 0.0004149 | 0.006798 |
285 | REGULATION OF ENERGY HOMEOSTASIS | 2 | 17 | 0.0004212 | 0.006805 |
286 | MAMMARY GLAND ALVEOLUS DEVELOPMENT | 2 | 17 | 0.0004212 | 0.006805 |
287 | MAMMARY GLAND LOBULE DEVELOPMENT | 2 | 17 | 0.0004212 | 0.006805 |
288 | RESPIRATORY SYSTEM DEVELOPMENT | 4 | 197 | 0.0004202 | 0.006805 |
289 | REGULATION OF TRANSLATIONAL INITIATION | 3 | 82 | 0.0004302 | 0.006926 |
290 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 5 | 360 | 0.0004379 | 0.007025 |
291 | RESPONSE TO ALCOHOL | 5 | 362 | 0.0004491 | 0.00718 |
292 | CIRCULATORY SYSTEM PROCESS | 5 | 366 | 0.0004721 | 0.00744 |
293 | CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 2 | 18 | 0.0004733 | 0.00744 |
294 | RESPONSE TO CAFFEINE | 2 | 18 | 0.0004733 | 0.00744 |
295 | MAST CELL MEDIATED IMMUNITY | 2 | 18 | 0.0004733 | 0.00744 |
296 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 4 | 203 | 0.0004706 | 0.00744 |
297 | SINGLE ORGANISM BIOSYNTHETIC PROCESS | 9 | 1340 | 0.0004779 | 0.007487 |
298 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 5 | 368 | 0.000484 | 0.007557 |
299 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 6 | 573 | 0.0005046 | 0.007853 |
300 | GERM CELL DEVELOPMENT | 4 | 209 | 0.0005252 | 0.008146 |
301 | REGULATION OF STEM CELL PROLIFERATION | 3 | 88 | 0.0005291 | 0.008152 |
302 | POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 3 | 88 | 0.0005291 | 0.008152 |
303 | ESTABLISHMENT OF LOCALIZATION IN CELL | 10 | 1676 | 0.0005564 | 0.008544 |
304 | REGULATION OF CELL CELL ADHESION | 5 | 380 | 0.0005599 | 0.00857 |
305 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 7 | 823 | 0.0005718 | 0.008724 |
306 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 8 | 1087 | 0.0005745 | 0.008735 |
307 | SECRETION | 6 | 588 | 0.0005783 | 0.008764 |
308 | EMBRYONIC HEMOPOIESIS | 2 | 20 | 0.0005864 | 0.008774 |
309 | CELLULAR RESPONSE TO LIGHT STIMULUS | 3 | 91 | 0.0005836 | 0.008774 |
310 | CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 2 | 20 | 0.0005864 | 0.008774 |
311 | RESPONSE TO MUSCLE ACTIVITY | 2 | 20 | 0.0005864 | 0.008774 |
312 | REGULATION OF CELL GROWTH | 5 | 391 | 0.0006371 | 0.009502 |
313 | MAST CELL ACTIVATION | 2 | 21 | 0.0006474 | 0.009506 |
314 | POSITIVE T CELL SELECTION | 2 | 21 | 0.0006474 | 0.009506 |
315 | REGULATION OF PROTEIN STABILITY | 4 | 221 | 0.0006476 | 0.009506 |
316 | POSITIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION | 2 | 21 | 0.0006474 | 0.009506 |
317 | NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 2 | 21 | 0.0006474 | 0.009506 |
318 | GLAND DEVELOPMENT | 5 | 395 | 0.0006671 | 0.009761 |
319 | CARDIOCYTE DIFFERENTIATION | 3 | 96 | 0.0006821 | 0.00995 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | KINASE ACTIVITY | 24 | 842 | 5.415e-25 | 5.03e-22 |
2 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 24 | 992 | 2.661e-23 | 1.236e-20 |
3 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 445 | 7.979e-21 | 2.471e-18 |
4 | PROTEIN KINASE ACTIVITY | 19 | 640 | 1.576e-19 | 3.66e-17 |
5 | ADENYL NUCLEOTIDE BINDING | 20 | 1514 | 7.626e-14 | 1.417e-11 |
6 | RIBONUCLEOTIDE BINDING | 20 | 1860 | 3.598e-12 | 5.572e-10 |
7 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 70 | 3.641e-11 | 4.832e-09 |
8 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 43 | 1.275e-10 | 1.48e-08 |
9 | PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 6 | 51 | 3.727e-10 | 3.847e-08 |
10 | KINASE BINDING | 11 | 606 | 5.449e-09 | 5.063e-07 |
11 | PHOSPHATIDYLINOSITOL PHOSPHATE KINASE ACTIVITY | 4 | 16 | 1.584e-08 | 1.338e-06 |
12 | KINASE REGULATOR ACTIVITY | 7 | 186 | 3.571e-08 | 2.765e-06 |
13 | ENZYME BINDING | 15 | 1737 | 1.09e-07 | 7.792e-06 |
14 | ENZYME REGULATOR ACTIVITY | 11 | 959 | 5.791e-07 | 3.843e-05 |
15 | INSULIN RECEPTOR SUBSTRATE BINDING | 3 | 11 | 8.75e-07 | 5.419e-05 |
16 | MOLECULAR FUNCTION REGULATOR | 12 | 1353 | 2.385e-06 | 0.0001385 |
17 | KINASE ACTIVATOR ACTIVITY | 4 | 62 | 4.578e-06 | 0.0002501 |
18 | INSULIN RECEPTOR BINDING | 3 | 32 | 2.563e-05 | 0.001323 |
19 | PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 3 | 39 | 4.681e-05 | 0.002289 |
20 | ENZYME ACTIVATOR ACTIVITY | 6 | 471 | 0.0001766 | 0.008205 |
21 | GROWTH FACTOR ACTIVITY | 4 | 160 | 0.0001903 | 0.00842 |
22 | PHOSPHATASE BINDING | 4 | 162 | 0.0001996 | 0.008429 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 7 | 20 | 2.509e-15 | 1.465e-12 |
2 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 11 | 237 | 2.374e-13 | 6.932e-11 |
3 | EXTRINSIC COMPONENT OF MEMBRANE | 8 | 252 | 1.268e-08 | 2.469e-06 |
4 | TRANSFERASE COMPLEX | 11 | 703 | 2.521e-08 | 3.681e-06 |
5 | CATALYTIC COMPLEX | 11 | 1038 | 1.265e-06 | 0.0001477 |
6 | PRE AUTOPHAGOSOMAL STRUCTURE | 3 | 31 | 2.325e-05 | 0.00194 |
7 | PROTEIN KINASE COMPLEX | 4 | 90 | 2.023e-05 | 0.00194 |
8 | PLATELET ALPHA GRANULE LUMEN | 3 | 55 | 0.0001318 | 0.009618 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | mTOR_signaling_pathway_hsa04150 | 29 | 151 | 1.33e-56 | 6.916e-55 | |
2 | PI3K_Akt_signaling_pathway_hsa04151 | 24 | 352 | 3.67e-34 | 9.541e-33 | |
3 | AMPK_signaling_pathway_hsa04152 | 19 | 121 | 1.282e-33 | 2.222e-32 | |
4 | Autophagy_animal_hsa04140 | 18 | 128 | 7.709e-31 | 1.002e-29 | |
5 | HIF_1_signaling_pathway_hsa04066 | 15 | 100 | 5.203e-26 | 5.411e-25 | |
6 | FoxO_signaling_pathway_hsa04068 | 13 | 132 | 5e-20 | 4.334e-19 | |
7 | ErbB_signaling_pathway_hsa04012 | 11 | 85 | 2.301e-18 | 1.709e-17 | |
8 | Focal_adhesion_hsa04510 | 13 | 199 | 1.193e-17 | 7.753e-17 | |
9 | Rap1_signaling_pathway_hsa04015 | 12 | 206 | 1.041e-15 | 6.014e-15 | |
10 | Phospholipase_D_signaling_pathway_hsa04072 | 10 | 146 | 6.799e-14 | 3.536e-13 | |
11 | VEGF_signaling_pathway_hsa04370 | 8 | 59 | 9.931e-14 | 4.695e-13 | |
12 | Ras_signaling_pathway_hsa04014 | 11 | 232 | 1.879e-13 | 8.141e-13 | |
13 | Apelin_signaling_pathway_hsa04371 | 9 | 137 | 2.049e-12 | 8.195e-12 | |
14 | Cellular_senescence_hsa04218 | 9 | 160 | 8.374e-12 | 3.11e-11 | |
15 | TNF_signaling_pathway_hsa04668 | 8 | 108 | 1.483e-11 | 5.141e-11 | |
16 | Sphingolipid_signaling_pathway_hsa04071 | 8 | 118 | 3.044e-11 | 9.892e-11 | |
17 | MAPK_signaling_pathway_hsa04010 | 10 | 295 | 7.584e-11 | 2.32e-10 | |
18 | Apoptosis_hsa04210 | 8 | 138 | 1.077e-10 | 3.11e-10 | |
19 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 8 | 139 | 1.141e-10 | 3.122e-10 | |
20 | cAMP_signaling_pathway_hsa04024 | 8 | 198 | 1.911e-09 | 4.969e-09 | |
21 | Regulation_of_actin_cytoskeleton_hsa04810 | 7 | 208 | 7.688e-08 | 1.904e-07 | |
22 | Jak_STAT_signaling_pathway_hsa04630 | 6 | 162 | 4.1e-07 | 9.691e-07 | |
23 | Phosphatidylinositol_signaling_system_hsa04070 | 5 | 99 | 8.959e-07 | 2.025e-06 | |
24 | Oocyte_meiosis_hsa04114 | 5 | 124 | 2.73e-06 | 5.916e-06 | |
25 | cGMP_PKG_signaling_pathway_hsa04022 | 4 | 163 | 0.0002044 | 0.0004251 | |
26 | TGF_beta_signaling_pathway_hsa04350 | 3 | 84 | 0.0004617 | 0.0009234 | |
27 | Tight_junction_hsa04530 | 3 | 170 | 0.003506 | 0.006753 | |
28 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.006102 | 0.01133 | |
29 | Cytokine_cytokine_receptor_interaction_hsa04060 | 2 | 270 | 0.08479 | 0.147 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | HAND2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 20 | IGF1 | Sponge network | 0.477 | 0.68532 | 0.163 | 0.73859 | 0.653 |
2 | EMX2OS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 21 | IGF1 | Sponge network | 0.136 | 0.87877 | 0.163 | 0.73859 | 0.631 |
3 | RP11-389C8.2 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-629-5p | 13 | IGF1 | Sponge network | 0.195 | 0.62434 | 0.163 | 0.73859 | 0.575 |
4 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 21 | IGF1 | Sponge network | 0.331 | 0.60413 | 0.163 | 0.73859 | 0.572 |
5 | RP11-887P2.5 |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-940 | 14 | IGF1 | Sponge network | 0.643 | 0.69431 | 0.163 | 0.73859 | 0.567 |
6 | AC003090.1 |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-576-5p;hsa-miR-590-3p | 14 | IGF1 | Sponge network | 0.466 | 0.8099 | 0.163 | 0.73859 | 0.561 |
7 | MIR497HG |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-940 | 13 | IGF1 | Sponge network | -0.497 | 0.59613 | 0.163 | 0.73859 | 0.518 |
8 | RP11-13K12.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-629-5p | 11 | IGF1 | Sponge network | 0.316 | 0.83639 | 0.163 | 0.73859 | 0.499 |
9 | ADAMTS9-AS1 |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 17 | IGF1 | Sponge network | 0.804 | 0.67055 | 0.163 | 0.73859 | 0.499 |
10 | MEG3 |
hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-940 | 15 | IGF1 | Sponge network | -0.058 | 0.92414 | 0.163 | 0.73859 | 0.498 |
11 | WT1-AS |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 18 | IGF1 | Sponge network | 0.547 | 0.65455 | 0.163 | 0.73859 | 0.493 |
12 | MIR143HG |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 17 | IGF1 | Sponge network | 0.188 | 0.86553 | 0.163 | 0.73859 | 0.49 |
13 | RP11-130L8.1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-590-3p | 12 | IGF1 | Sponge network | 0.181 | 0.7061 | 0.163 | 0.73859 | 0.487 |
14 | DNM3OS |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 19 | IGF1 | Sponge network | -0.264 | 0.65518 | 0.163 | 0.73859 | 0.483 |
15 | PGM5-AS1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-940 | 11 | IGF1 | Sponge network | 0.612 | 0.76641 | 0.163 | 0.73859 | 0.481 |
16 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 20 | IGF1 | Sponge network | 0.333 | 0.48662 | 0.163 | 0.73859 | 0.477 |
17 | PWAR6 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-629-5p | 12 | IGF1 | Sponge network | -0.138 | 0.85495 | 0.163 | 0.73859 | 0.454 |
18 | MAGI2-AS3 |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-3065-5p;hsa-miR-362-3p;hsa-miR-93-5p | 10 | AKT3 | Sponge network | 0.331 | 0.60413 | 0.2 | 0.64987 | 0.454 |
19 | CTB-92J24.3 | hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p | 11 | IGF1 | Sponge network | -0.934 | 0.54672 | 0.163 | 0.73859 | 0.445 |
20 | RP11-774O3.3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-590-3p | 10 | IGF1 | Sponge network | 0.004 | 0.98793 | 0.163 | 0.73859 | 0.438 |
21 | RP11-384L8.1 | hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-330-3p;hsa-miR-590-3p | 10 | PRKAA2 | Sponge network | 0.327 | 0.67861 | 0.394 | 0.45499 | 0.433 |
22 | RP11-116O18.1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-590-3p | 13 | IGF1 | Sponge network | 2.549 | 0.22529 | 0.163 | 0.73859 | 0.431 |
23 | RP11-760H22.2 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-629-5p | 10 | IGF1 | Sponge network | -0.315 | 0.56614 | 0.163 | 0.73859 | 0.429 |
24 | RP11-150O12.3 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-629-5p | 13 | IGF1 | Sponge network | 1.029 | 0.56311 | 0.163 | 0.73859 | 0.425 |
25 | CTD-2554C21.3 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-320b | 13 | IGF1 | Sponge network | 1.479 | 0.3461 | 0.163 | 0.73859 | 0.416 |
26 | LINC00861 | hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-486-5p;hsa-miR-940 | 10 | IGF1 | Sponge network | -0.722 | 0.42012 | 0.163 | 0.73859 | 0.416 |
27 | AC073283.4 | hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-31-5p;hsa-miR-342-3p;hsa-miR-34c-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | -0.143 | 0.89572 | 0.394 | 0.45499 | 0.412 |
28 | TRHDE-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-590-3p;hsa-miR-940 | 16 | IGF1 | Sponge network | -0.585 | 0.75149 | 0.163 | 0.73859 | 0.412 |
29 | NR2F1-AS1 |
hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-452-5p;hsa-miR-454-3p;hsa-miR-590-3p;hsa-miR-629-5p | 13 | IGF1 | Sponge network | -0.165 | 0.76959 | 0.163 | 0.73859 | 0.41 |
30 | RP11-166D19.1 |
hsa-miR-1271-5p;hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-429;hsa-miR-532-3p;hsa-miR-9-5p;hsa-miR-93-3p | 14 | RPS6KA2 | Sponge network | 0.333 | 0.48662 | 0.207 | 0.72583 | 0.408 |
31 | RASSF8-AS1 | hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-342-3p;hsa-miR-590-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | 0.247 | 0.63827 | 0.394 | 0.45499 | 0.401 |
32 | LINC00284 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-629-5p | 14 | IGF1 | Sponge network | 0.193 | 0.90734 | 0.163 | 0.73859 | 0.397 |
33 | NR2F2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-576-5p;hsa-miR-590-3p | 13 | IGF1 | Sponge network | 0.833 | 0.42212 | 0.163 | 0.73859 | 0.391 |
34 | ZNF582-AS1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-576-5p | 13 | IGF1 | Sponge network | 0.019 | 0.98367 | 0.163 | 0.73859 | 0.39 |
35 | CTD-2554C21.2 |
hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-452-5p;hsa-miR-486-5p;hsa-miR-629-5p | 13 | IGF1 | Sponge network | 0.42 | 0.81173 | 0.163 | 0.73859 | 0.387 |
36 | ZNF667-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-629-5p | 13 | IGF1 | Sponge network | 0.158 | 0.77515 | 0.163 | 0.73859 | 0.383 |
37 | FAM66C | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-590-3p;hsa-miR-940 | 14 | IGF1 | Sponge network | 0.289 | 0.68737 | 0.163 | 0.73859 | 0.38 |
38 | SNHG14 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-452-5p;hsa-miR-629-5p | 11 | IGF1 | Sponge network | 0.178 | 0.79544 | 0.163 | 0.73859 | 0.362 |
39 | RP11-355F16.1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-32-3p;hsa-miR-590-3p;hsa-miR-629-5p;hsa-miR-940 | 11 | IGF1 | Sponge network | -0.351 | 0.67994 | 0.163 | 0.73859 | 0.359 |
40 | AC003090.1 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-320b;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-582-5p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p | 15 | PIK3R1 | Sponge network | 0.466 | 0.8099 | -0.149 | 0.83268 | 0.358 |
41 | DNM3OS |
hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-142-3p;hsa-miR-15a-5p;hsa-miR-15b-5p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-3065-5p;hsa-miR-502-3p;hsa-miR-93-5p | 10 | AKT3 | Sponge network | -0.264 | 0.65518 | 0.2 | 0.64987 | 0.354 |
42 | LINC00284 |
hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | 0.193 | 0.90734 | 0.394 | 0.45499 | 0.354 |
43 | RP11-760H22.2 |
hsa-let-7f-1-3p;hsa-let-7i-5p;hsa-miR-142-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-31-5p;hsa-miR-342-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | -0.315 | 0.56614 | 0.394 | 0.45499 | 0.344 |
44 | RP11-344E13.3 |
hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-320b;hsa-miR-454-3p;hsa-miR-486-5p;hsa-miR-590-3p | 10 | IGF1 | Sponge network | 0.625 | 0.50491 | 0.163 | 0.73859 | 0.334 |
45 | ACTA2-AS1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-3p;hsa-miR-940 | 17 | IGF1 | Sponge network | -0.694 | 0.57395 | 0.163 | 0.73859 | 0.332 |
46 | MAGI2-AS3 |
hsa-miR-130b-5p;hsa-miR-17-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-200b-3p;hsa-miR-200c-3p;hsa-miR-21-3p;hsa-miR-30e-5p;hsa-miR-378a-3p;hsa-miR-378c;hsa-miR-429;hsa-miR-532-3p;hsa-miR-9-3p;hsa-miR-93-3p | 15 | RPS6KA2 | Sponge network | 0.331 | 0.60413 | 0.207 | 0.72583 | 0.332 |
47 | LINC00261 | hsa-let-7f-1-3p;hsa-let-7i-5p;hsa-miR-142-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-34c-3p;hsa-miR-34c-5p;hsa-miR-590-3p | 11 | PRKAA2 | Sponge network | 1.024 | 0.64032 | 0.394 | 0.45499 | 0.322 |
48 | USP3-AS1 |
hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-452-5p;hsa-miR-486-5p | 11 | IGF1 | Sponge network | 0.062 | 0.93059 | 0.163 | 0.73859 | 0.321 |
49 | HOXA11-AS | hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-452-5p;hsa-miR-454-3p | 10 | IGF1 | Sponge network | 0.402 | 0.37439 | 0.163 | 0.73859 | 0.321 |
50 | MIR497HG |
hsa-miR-1301-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-320c;hsa-miR-584-5p;hsa-miR-590-5p;hsa-miR-629-3p | 13 | PIK3R1 | Sponge network | -0.497 | 0.59613 | -0.149 | 0.83268 | 0.307 |
51 | MLLT4-AS1 | hsa-let-7f-1-3p;hsa-let-7i-5p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-146b-5p;hsa-miR-150-3p;hsa-miR-22-5p;hsa-miR-27b-5p;hsa-miR-330-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | -0.083 | 0.90482 | 0.394 | 0.45499 | 0.305 |
52 | RP11-774O3.3 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-590-3p;hsa-miR-629-3p | 14 | PIK3R1 | Sponge network | 0.004 | 0.98793 | -0.149 | 0.83268 | 0.303 |
53 | CTC-559E9.5 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-301a-3p;hsa-miR-576-5p;hsa-miR-629-5p | 12 | IGF1 | Sponge network | -0.273 | 0.54146 | 0.163 | 0.73859 | 0.301 |
54 | TPTEP1 |
hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-590-3p;hsa-miR-940 | 12 | IGF1 | Sponge network | 0.213 | 0.82899 | 0.163 | 0.73859 | 0.298 |
55 | RP11-389C8.2 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-22-5p;hsa-miR-3065-5p;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-629-3p | 11 | PIK3R1 | Sponge network | 0.195 | 0.62434 | -0.149 | 0.83268 | 0.297 |
56 | NR2F1-AS1 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-629-3p | 12 | PIK3R1 | Sponge network | -0.165 | 0.76959 | -0.149 | 0.83268 | 0.292 |
57 | RP11-567M16.1 | hsa-miR-1301-3p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-29b-3p;hsa-miR-320b;hsa-miR-330-3p;hsa-miR-335-3p;hsa-miR-590-5p;hsa-miR-629-3p | 11 | PIK3R1 | Sponge network | 0.111 | 0.93576 | -0.149 | 0.83268 | 0.286 |
58 | DNM3OS |
hsa-miR-1301-3p;hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-3065-5p;hsa-miR-32-3p;hsa-miR-320b;hsa-miR-320c;hsa-miR-330-3p;hsa-miR-590-3p;hsa-miR-590-5p;hsa-miR-629-3p | 15 | PIK3R1 | Sponge network | -0.264 | 0.65518 | -0.149 | 0.83268 | 0.285 |
59 | LINC00284 |
hsa-miR-18a-3p;hsa-miR-19b-3p;hsa-miR-222-5p;hsa-miR-29b-1-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-365a-3p;hsa-miR-511-5p;hsa-miR-590-3p;hsa-miR-590-5p | 10 | PIK3R3 | Sponge network | 0.193 | 0.90734 | 0.01 | 0.98958 | 0.283 |
60 | RP11-627G23.1 | hsa-let-7a-3p;hsa-let-7f-1-3p;hsa-miR-15b-3p;hsa-miR-16-1-3p;hsa-miR-19b-1-5p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-33a-3p;hsa-miR-452-5p;hsa-miR-940 | 10 | IGF1 | Sponge network | 0.142 | 0.94224 | 0.163 | 0.73859 | 0.282 |
61 | NR2F1-AS1 |
hsa-miR-18a-3p;hsa-miR-19b-3p;hsa-miR-222-5p;hsa-miR-29b-1-5p;hsa-miR-32-5p;hsa-miR-330-3p;hsa-miR-330-5p;hsa-miR-365a-3p;hsa-miR-511-5p;hsa-miR-590-3p;hsa-miR-92a-3p | 11 | PIK3R3 | Sponge network | -0.165 | 0.76959 | 0.01 | 0.98958 | 0.279 |
62 | AC016582.2 |
hsa-let-7f-1-3p;hsa-miR-103a-2-5p;hsa-miR-15b-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-27a-3p;hsa-miR-320b;hsa-miR-576-5p;hsa-miR-590-3p | 11 | IGF1 | Sponge network | 0.564 | 0.78079 | 0.163 | 0.73859 | 0.278 |
63 | ZNF667-AS1 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-29b-3p;hsa-miR-320c;hsa-miR-590-5p;hsa-miR-629-3p | 11 | PIK3R1 | Sponge network | 0.158 | 0.77515 | -0.149 | 0.83268 | 0.273 |
64 | EMX2OS |
hsa-let-7f-1-3p;hsa-miR-142-5p;hsa-miR-22-5p;hsa-miR-23a-3p;hsa-miR-27b-5p;hsa-miR-31-5p;hsa-miR-330-3p;hsa-miR-342-3p;hsa-miR-590-3p;hsa-miR-944 | 10 | PRKAA2 | Sponge network | 0.136 | 0.87877 | 0.394 | 0.45499 | 0.272 |
65 | RP11-597D13.9 |
hsa-miR-103a-2-5p;hsa-miR-130b-3p;hsa-miR-15b-3p;hsa-miR-19a-3p;hsa-miR-19b-1-5p;hsa-miR-19b-3p;hsa-miR-20a-3p;hsa-miR-301a-3p;hsa-miR-32-3p;hsa-miR-33a-3p;hsa-miR-454-3p | 11 | IGF1 | Sponge network | -0.325 | 0.74209 | 0.163 | 0.73859 | 0.271 |
66 | ACTA2-AS1 |
hsa-miR-16-2-3p;hsa-miR-16-5p;hsa-miR-17-5p;hsa-miR-182-5p;hsa-miR-200c-3p;hsa-miR-20a-5p;hsa-miR-21-5p;hsa-miR-22-5p;hsa-miR-29b-3p;hsa-miR-590-3p | 10 | PIK3R1 | Sponge network | -0.694 | 0.57395 | -0.149 | 0.83268 | 0.264 |